FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Arbor Pharmaceuticals Nymalize Recall

Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringe…

Arbor Pharmaceuticals Inc. · Atlanta, GA

Risk level
Class III
Reported by FDA
Oct 7, 2020
Recall ID
D-1625-2020
Check your lot numberHow we source this data

Summary

Arbor Pharmaceuticals recalled Nymalize starting Sep 16, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1625-2020 on Oct 7, 2020. Reason: Subpotent Drug. Status: Terminated.

Why it was recalled

Subpotent Drug

Product description

Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12

Lot numbers, UPCs & expiration codes

Lot #: 356884 Exp. 11/30/2021

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1625-2020
Classification
Class III
Status
Terminated
Recall initiated
Sep 16, 2020
FDA report date
Oct 7, 2020
Quantity
1846 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Arbor Pharmaceuticals Inc.

Original FDA data

Every field from FDA enforcement report D-1625-2020, exactly as published.

Show all FDA fields
City
Atlanta
State
GA
Status
Terminated
Country
United States
Event ID
86392
Address
6 Concourse Pkwy Ste 1800
Code information
Lot #: 356884 Exp. 11/30/2021
Postal code
30328-5353
Report date
Oct 7, 2020
Product type
Drugs
Recall number
D-1625-2020
Classification
Class III
Recalling firm
Arbor Pharmaceuticals Inc.
Product quantity
1846 cartons
Termination date
Feb 22, 2022
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Nymalize (nimodipine) oral solution, 60 mg/20 mL, 12 Unit-Dose Cups and 12 Oral Syringes, 2 inner cartons per outer shipping carton, Rx Only, Distributed by arbor Atlanta, GA, NDC 24338-200-12
Distribution pattern
Nationwide within the United States
Recall initiation date
Sep 16, 2020
Initial firm notification
Letter
Center classification date
Sep 28, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1625-2020, published Oct 7, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls